Huvepharma returns to family control

Investment group completes sale of its 36.6% holding in Huvepharma to Domuschiev family, which now controls 100% of the animal health company.

The Rohatyn Group (TRG), an independent investment firm focused on emerging markets, announced Nov. 20 that TRG Growth Fund II has finalized the sale of its 36.6% shareholding in Huvepharma AD to Advance Properties OOD, a company controlled by the Domuschiev family.

Huvepharma, headquartered in Sofia, Bulgaria, is a global fully integrated pharmaceutical company focused on developing, manufacturing and marketing animal health and nutrition products, as well as several key ingredients used in human health products. As a result of this transaction, Advance Properties effectively controls 100% of Huvepharma, according to the announcement.

"TRG has been a strong partner for Huvepharma and we are pleased with their contribution to the rapid international development and growth of the company. We are excited that Advance Properties again holds a 100% controlling interest of Huvepharma and continues to support the company in the pursuit of further growth strategies," Huvepharma president Kiril Domuschiev said. "The combination of an experienced management team and staff and continued investment in product development and global production facilities gives us full confidence that Huvepharma is well placed to sustain an ambitious growth path."

Huvepharma, founded in 2000 by the Domuschiev family, has worldwide operations with 99% of its production sold outside of Bulgaria in more than 95 countries. Huvepharma's key product categories are feed additives and veterinary products for food-producing animals and active human pharmaceutical ingredients.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.